Received Jan 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z008220 | — |
No side effects or symptoms reported; a 15-year-old patient received a dose of PROQUAD; This spontaneous report was received from a nurse and refers to a 15-year-old female patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 28-Oct-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), Powder and solvent for solution for injection, at a total dose of 0.5 ml (valid lot #Z008220, expiration date reported and confirmed as 27-Oct-2026; route of administration and anatomical location were not provided) as prophylaxis (product administered to patient of inappropriate age). The suspect vaccine was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT) solution for injection (lot # and expiration date were not reported). No side effects or symptoms reported (no adverse event). The reporter informed that the event was noticed on 23-Jan-2026.
Sterile diluent